The fibromyalgia market is primarily driven by the increasing prevalence of various triggering factors, including neurotransmitter imbalances, exposure to toxins, and infections such as Lyme disease, Hepatitis C, and physical or emotional trauma.

1. Fibromyalgia
Market Research
Report 2023-
2033

2. ABOUT IMARC
2
International Market Analysis Research and Consulting Group is a
leading adviser on management strategy and market research
worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their
most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific,
economic and technological developments for business leaders in
pharmaceutical, industrial, and high technology organizations.
Market forecasts and industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel and tourism,
nanotechnology and novel processing methods are at the top of
the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into
the dynamics of companies and markets with close cooperation at
all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient
organizations, and secure lasting results.

3. Report Description and Highlights
Fibromyalgia Market 2023-2033
IMARC Group has recently released a report titled “Fibromyalgia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity,
and Forecast 2023-2033” that presents a comprehensive assessment of the fibromyalgia market size. The report provides an extensive
overview of the latest market trends, growth prospects, investment opportunities, and industry outlook, as well as an in-depth analysis of
the disease landscape, market scenario, and growth trends. Furthermore, the report offers an analysis of competitors, regional markets,
and recent advancements in the global market. It also sheds light on crucial segments and market drivers, along with challenges faced by
industry players. This report is a valuable resource for stakeholders who want to gain valuable insights into the fibromyalgia market.
What is fibromyalgia?
Fibromyalgia refers to a chronic health condition that causes pain and tenderness throughout the body. Its symptoms include muscle
tenderness, fatigue, facial and jaw pain, headaches, bladder control problems, and gastrointestinal issues, such as diarrhea and
constipation. In severe cases, individuals with fibromyalgia may experience emotional and mental indications, including impaired memory,
anxiety, depression, insomnia, heightened sensitivity to stimuli, and other sleep disorders. Its diagnosis is challenging, as there are no
specific tests or imaging studies that can definitively confirm the condition. 3

4. Report Description and Highlights
Instead, healthcare professionals conduct a thorough evaluation of medical history and physical examination to exclude other potential
causes for the symptoms. Along with this, the magnetic resonance imaging (MRI) technique is also employed in the diagnosis process as it
can measure and map brain activity, aiding in identifying the patient’s specific subtype of the syndrome.
What are the key drivers and trends in the fibromyalgia market?
The fibromyalgia market is primarily driven by the increasing prevalence of various triggering factors, including neurotransmitter
imbalances, exposure to toxins, and infections such as Lyme disease, Hepatitis C, and physical or emotional trauma. Additionally, the
expanding female population, with hormonal changes and increased stress during menstruation, menopause, or pregnancy, is acting as
another growth-inducing factor. Furthermore, the widespread adoption of effective medications, such as serotonin-norepinephrine
reuptake inhibitors, muscle relaxants, and non-steroidal anti-inflammatory drugs, which aid in reducing pain and improving the quality of
life for patients, is boosting the market growth. Besides this, the application of combined diagnostic criteria, including symptom severity
scales, widespread pain indexes, and fibromyalgianess scales, which assist in specific detection of the condition, is favoring the market
growth.
4

5. Report Description and Highlights
Moreover, the increasing investments by key players in research and development activities to introduce thermal therapies that can modify
nerve conduction and alleviate pain are catalyzing the market growth.
Request a Sample Report: https://www.imarcgroup.com/fibromyalgia-market/requestsample
5

6. Report Description and Highlights
What is included in the report segmentation?
The report covers the following aspects:
Report Period:
• Base Year: 2022
• Historical Period: 2017-2022
• Market Forecast: 2023-2033
Countries Included:
• United States
• Germany
• France
6

7. Report Description and Highlights
• United Kingdom
• Italy
• Spain
• Japan
Analysis Covered Across Each Country
• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the Fibromyalgia market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the Fibromyalgia market
• Reimbursement scenario in the market
• In-market and pipeline drugs
7

8. Report Description and Highlights
In-Market Drugs
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Regulatory Status
View Report TOC, Figures and Tables: https://www.imarcgroup.com/fibromyalgia-market
8

9. Key Questions Answered in the Report
1. How has the Fibromyalgia Market performed so far and how will it perform in the coming years?
2. What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
3. What was the country-wise size of the Fibromyalgia Market across the seven major markets in 2022 and what will it look like in 2033?
4. What is the growth rate of the Fibromyalgia Market across the seven major markets and what will be the expected growth over the
next ten years?
5. What are the key unmet needs in the market?
9

10. Table of
Contents

11. Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
11

12. Table of Contents
4 Fibromyalgia - Introduction
4.1 Overview
4.2 Regulatory Process
4.3 Epidemiology (2017-2022) and Forecast (2023-2033)
4.4 Market Overview (2017-2022) and Forecast (2023-2033)
4.5 Competitive Intelligence
5 Fibromyalgia - Disease Overview
5.1 Introduction
5.2 Symptoms and Diagnosis
5.3 Pathophysiology
5.4 Causes and Risk Factors
5.5 Treatment
Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/fibromyalgia-market/toc
12

13. Partial List Of Our Clients
13

14. OUR CLIENTS
14

15. Disclaimer
15
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis
Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or
in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including
photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information
and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting
makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts
no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and
Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.